Resmed (RSMDF) Work In Process (2010 - 2026)

Resmed has reported Work In Process for 17 years, with the latest figure at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process fell 39.32% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 39.32% YoY), and the FY2025 full-year result was $2.6 million, down 6.01% from the prior year.
• Work In Process for Q1 2026 stood at $2.0 million, up from $968000.0 in the prior quarter.
• The five-year high for Work In Process was $5.2 million in Q3 2023, with the low at $968000.0 in Q4 2025.
• Historically, Work In Process has averaged $3.0 million across 5 years, with a median of $2.9 million in 2023.
• The largest YoY upside for Work In Process was 77.67% in 2025 against a maximum downside of 62.29% in 2025.
• Resmed's Work In Process stood at $3.0 million in 2022, then dropped by 2.42% to $2.9 million in 2023, then decreased by 12.75% to $2.6 million in 2024, then sank by 62.29% to $968000.0 in 2025, then soared by 105.48% to $2.0 million in 2026.
• The last three Work In Process figures came in at $2.0 million (Q1 2026), $968000.0 (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.